In breast cancer, the expression level of IGF-II is positively correlated with the expression levels of the anti-apoptotic proteins Bcl-2, Bcl-XL and survivin (136); thus IGF-II can promote the development of tumors by accelerating tumor growth, inhibiting cancer cell apoptosis and promoting tumor cell metastasis. Here, IGF2 is linked to neoplasm.